Total Equity
Bristol-Myers Squibb Total Equity increased by 8.6% to $20.07B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.4%, from $17.39B to $20.07B. Over 5 years (FY 2020 to FY 2025), Total Equity shows a downward trend with a -13.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase generally indicates growth in the company's net worth through earnings or capital contributions, while a decrease may signal losses or aggressive capital returns.
Detailed definition
Total stockholders' equity represents the residual interest in the assets of the company after deducting all liabilities...
Peer comparison
This is a fundamental measure of financial health used to calculate return on equity (ROE) across the pharmaceutical sector.
total_stockholders_equityHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $36.81B | $37.21B | $35.95B | $31.58B | $32.60B | $32.67B | $31.06B | $31.82B | $31.97B | $29.00B | $29.43B | $16.49B | $17.02B | $17.14B | $16.34B | $17.39B | $17.44B | $18.55B | $18.47B | $20.07B |
| QoQ Change | — | +1.1% | -3.4% | -12.1% | +3.2% | +0.2% | -4.9% | +2.5% | +0.5% | -9.3% | +1.5% | -44.0% | +3.2% | +0.7% | -4.7% | +6.5% | +0.3% | +6.4% | -0.4% | +8.6% |
| YoY Change | — | — | — | — | -11.4% | -12.2% | -13.6% | +0.8% | -1.9% | -11.2% | -5.3% | -48.2% | -46.8% | -40.9% | -44.5% | +5.5% | +2.5% | +8.2% | +13.1% | +15.4% |
Total Equity at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's total equity?
- Bristol-Myers Squibb (BMY) reported total equity of $20.07B in Q1 2026.
- How has Bristol-Myers Squibb's total equity changed year-over-year?
- Bristol-Myers Squibb's total equity increased by 15.4% year-over-year, from $17.39B to $20.07B.
- What is the long-term trend for Bristol-Myers Squibb's total equity?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's total equity has grown at a -13.4% compound annual growth rate (CAGR), from $37.82B to $18.47B.
- What does total equity mean?
- The total net value of the company belonging to shareholders.